Treatment with antidepressant and anti-anxiety medications after breast cancer diagnosis in a large HMO. Background: Dermatologic toxicities (dT) to epidermal growth factor receptor inhibitors (EGFRI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback